New Jersey-based Kenvue Inc. (KVUE) is a consumer health company operating across the Americas, Europe, EMEA, and the Indo-Pacific. It operates through Self Care, Skin Health and Beauty, and Essential Health segments. With a market cap of $42.9 billion, Kenvue owns several well-known brands like Listerine, BAND-AID, Tylenol, Neutrogena, and more.
The company has underperformed the broader market in 2025 but outpaced it over the past year. KVUE stock has inched up 3.8% on a YTD basis and soared 17.9% over the past 52 weeks, compared to the S&P 500 Index’s ($SPX) 8.3% gains in 2025 and 16.6% surge over the past year.
